Understanding Cerebellar Development and Disease
Welcome to the Becker Group!
We are interested in discovering the genes and biological mechanisms that regulate the development of the cerebellum and in exploring how the impairment of these mechanisms leads to cerebellar diseases.
The cerebellum is known as the primary centre of motor coordination and learning in the central nervous system. In addition, increasing evidence suggests that the "little brain" also contributes to higher cognitive functions including language, emotion and social reward processing. We understand surprisingly little about the molecular processes that underlie the formation of this complex brain structure and that, when disrupted, lead to disease. The goal of our research is to provide fundamental insights into the genetic, molecular and cellular mechanisms that govern the development and different diseases of the cerebellum. In particular, we use multi-disciplinary approaches to better understand the disease mechanisms responsible for disorders such as cerebellar ataxia and autism spectrum disorder. Together, our work is helping to provide a more rigorous understanding of the genes and pathways behind these diseases. We hope that our findings will ultimately help to inspire improved clinical treatments.
The cerebellar ataxias are a genetically and clinically diverse group of neurological conditions that primarily affect the cerebellum. A major challenge is to better understand the specific disease-causing mechanisms underlying this complex group of diseases and to identify common pathological pathways that could be targeted therapeutically. One of the emerging key players in cerebellar ataxia is TRPC3, a calcium-permeable ion channel of the transient receptor potential (TRP) family. We have discovered that mutations in the TRPC3 gene cause cerebellar ataxia in the Moonwalker (Mwk) mouse, as well as in human patients. The latter has been designated Spinocerebellar Ataxia type 41 (SCA41). Our ongoing work focuses on the discovery of additional mutations linked to the TRPC3 pathway and their functional and pathological characterisation. Most recently, we have identified the first dominant mutations in the GRM1 gene, encoding the metabotropic glutamate receptor mGluR1, causing Spinocerebellar Ataxia type 44 (SCA44).
Interestingly, the cerebellum has emerged as one of the key brain areas affected in autism spectrum disorder. However, the molecular mechanisms linking cerebellar function to autism remain largely unknown. We are addressing this important question by investigating the role of autism genes in the development and function of the cerebellum by integrating experimental developmental neurobiology and computational analyses. Our recent work has shown that a subset of autism genes is highly enriched in developing Purkinje cells.
Induced pluripotent stem cells
Our group is one of the few laboratories worldwide who have developed a robust protocol to generate cerebellar neurons from human induced pluripotent stem cells (iPSCs). This exciting technology allows us, for the first time, to study the development of human cerebellar neurons in the dish using available cells from healthy people as well as patients with ataxia and autism. We are combining this technology with CRISPR/Cas9 genome engineering to generate unique and isogenic human cerebellar disease models.
sources of Funding
- The Royal Society
- The Wellcome Trust
- John Fell OUP Research Fund
- Rosetrees Trust
- National Ataxia Foundation
Join the lab
We are a young and enthusiastic group. Enquiries from motivated and talented students and post-docs to discuss available research projects and funding possibilities are always welcome. Get in touch
Opportunities for DPhil/PhD projects in the Becker group are available through a number of graduate programmes:
Wellcome Trust Doctoral Programme in Neuroscience
Interdisciplinary Bioscience Doctoral Training Partnership
January 2019: Our cerebellar differentiation paper has been voted "Best 2018 Paper" in Cerebellum
August 2018: We are excited to host In2Science student Emma Davies for a placement in our group.
May 2018: Alaa Baazaoui, MSc project student from Cologne, joins our group. Welcome!
April 2018: Welcome to DTP rotation student Elise Padbury!
January 2018: Welcome to DTP rotation student Melissa Grant-Hänni!
October 2017: Great article by Lauren on 'iPSC-based models of neurodegenerative diseases: promises and pitfalls' in this term's issue of Phenotype
September 2017: Welcome to Mimi Prickett, who will carry out her Biochemistry Part II project in our group
July 2017: Welcome to Sixth-Former Emma Quartermain, who joins us for her In2Science work experience!
May 2017: Congratulations to Esther for winning the 2016 UK Golden Triangle Discovery Fast Track Challenge from GSK
May 2017: Congratulations to Lauren for winning a prestigious Masao Ito poster award at the recent 8th International Symposium of the Society for Research on the Cerebellum
May 2017: Great to see the Becker Group featured for World Cultural Diversity Day on the University's website
April 2017: Welcome to postdoctoral fellow Sam Nayler who joins us from Australia supported by an Oxford Nuffield Medical Fellowship and BrAshA-T
March 2017: Congratulations to Maggie, who has won the Gotch Memorial Prize for best DPhil Transfer Status report of a graduate student in the field of physiology at Oxford!
Reaching out to the public
Find out more about the Becker Group and the Functional Genomics Unit's public engagement here.
Esther was one of the invited keynote speakers at the "Empowered Women" event in April 2014 that was hosted by the Charity Wishful Smiles together with Barry Gardiner MP at the Houses of Parliament.